Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Birth weight range: 500g\~1250g~* Fetal gestational age: 23 weeks to 29 weeks~* Premature infants who cannot do spontaneous breathing, which ventilation rate is less than 12 breaths per min of ventilation rate and 25% of oxygen demand~* Premature infants who does not improve the breathing or worse within 24 hours prior to enrollment of this study~* Written consent form signed by a legal representative or a parent~Exclusion Criteria:~* Cyanotic or acyanotic congenital heart diseases except patent ductus arteriosus~* Severe lung malformation (i.e. Pulmonary hypoplasia, congenital diaphragmatic hernia, congenital cystic lung disease)~* Severe lung malformation with chromosome anomalies (i.e. Edward syndrome, Patau syndrome, Down syndrome, etc) or severe congenital malformation (Hydrocephalus, Encephalocele, etc)~* Severe congenital infection (i.e. Herpes, Toxoplasmosis, Rubella, Syphilis, AIDS, etc)~* CRP \> 30 mg/dL; Severe sepsis or shock~* Premature infants who is going to or expected to have surgery 72 hours before/after this study drug administration~* Surfactant administration within 24 hours prior to this study drug administration~* Severe intracranial hemorrhage ≥ grade 3 or 4~* Premature infants who have active pulmonary hemorrhage or active air leak syndrome at the time point of screening~* History of other clinical studies as a participant~* Premature infants who are allergic to Gentamicin~* Premature infants who is considered inappropriate by the investigators

- Gender: ALL
- Minimum Age: 5 Days
- Maximum Age: 14 Days
- Healthy Volunteers: f

Study Arms:
- PNEUMOSTEM® (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).